Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Marlene Santos has a total of 220 co-authors. Here are the top co-authors by number of shared publications:

  • Maria Fatima Barroso

    LAQV-REQUIMTE, Instituto Superior de Engenharia do Porto, Instituto Politécnico do Porto, Rua Dr. António Bernardino de Almeida 431, 4200-072 Porto, Portugal

    13 shared publications
  • Agostinho Cruz

    REQUIMTE/LAQV, ESS, Polytechnic of Porto, Rua Dr. António Bernardino de Almeida, 4200-072 Porto, Portugal

    9 shared publications
  • Stephanie Lopes Morais

    REQUIMTE/LAQV, Instituto Superior de Engenharia do Porto, Instituto Politécnico do Porto, Rua Dr. António Bernardino de Almeida 431, 4249-015 Porto, Portugal

    9 shared publications
  • Cristina Delerue-Matos

    REQUIMTE/LAQV, ISEP/IPP—Polytechnic of Porto—School of Engineering, Rua Doutor António Bernardino de Almeida, 431, 4249-015 Porto, Portugal

    7 shared publications
  • Luís Lima

    Experimental Pathology and Therapeutics Group, Research Centre of IPO Porto (CI- IPOP)/RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto (IPO Porto), Porto Comprehensive Cancer Centre (Porto.CCC), Porto, Portugal

    7 shared publications
  • Rui Medeiros

    Molecular Oncology and Viral Pathology Group, Department of Pathology and Laboratory Medicine/RISE - Associate Laboratory (Health Research Network), IPO Porto Research Centre (CI-IPOP), Portuguese Oncology Institute of Porto (IPO Porto), Porto Comprehensive Cancer Centre Raquel Seruca (Porto.CCC), Porto, 4200-072, Portugal.

    7 shared publications

Latest Publications

  • Open Access

    Botanical authentication of honey: Using electrochemical genosensors and RT-qPCR for the detection of Castanea sativa

    by Stephanie Morais, Eduarda Pereira, Mariana Ferreira, Marlene Paulo Santos, Sónia Soares, Ana Luísa Teixeira, Valentina Fernandes Domingues, Cristina Delerue-Matos, Maria F. Barroso

    Food fraud is a reoccurring issue for the food industry, with significant public health and economic implications. Honey, a natural ingredient prized for its nutritional profile and health benefits, is one of the most frequently adulterated foods. This fraudulent act presents a hazard to the consumers’ health. In this study, a disposable electrochemical genosensor was developed to detect Castanea sativa (chestnut tree) DNA in commercial honey. For this, a 103 bp C. sativa specific DNA-target oligonucleotide and its complementary probe were selected and designed. The genosensor methodology implied a sandwich hybridization format, for which the complementary sequence was in silico cut into a 22 bp thiolated DNA-capture probe and an 81 bp fluorescein isothiocyanate-labelled DNA probe. Using chronoamperometry, the enzymatic amplification of the electrochemical signal was obtained in a 0.03 to 1.00 nM concentration range, with a LOD and LOQ of 3.01 and 10.04 pM, respectively. The developed genosensor was able to detect the presence of the chestnut DNA in real chestnut plants and commercial honey samples. These results were successfully validated by real-time quantitative PCR (RT-qPCR). Therefore, electrochemical genosensors are a promising and cost-effective analytical tool to authenticate the botanical origin of honey, guaranteeing its safety, quality and authenticity.

  • Open Access

    Data from the Researcher Mental Health Observatory STAIRCASE Survey

    by Jana Lasser, Stefan T. Mol, Alja Čontala, Ana Slavec, Andreja Zulim de Swarte, Anna Khachatryan, Anna Maria Eleuteri, Anupoma Haque, Baiba Jansone, Blerina Vrenozi, et al.

    The data presented here derives from the Sustainable Working Conditions in Academia survey (STAIRCASE) on researcher mental health. The survey addresses the ongoing mental health crisis in academia by providing comprehensive, multilevel data on researcher well-being and its structural determinants. We employed a cross-sectional between-participant study design to collect data from 4,296 researchers between September 15, 2023, and August 26, 2024. The sample, which primarily includes researchers based in European countries, has a mean age of 38.1 years (SD = 10.7) and consists of 63.7% female participants. Participants provided data on key mental health outcomes – including depression, anxiety, stress, burnout, and well-being – alongside detailed assessments of working conditions, leadership behavior, and organizational characteristics. The dataset facilitates a holistic, multilevel investigation of academic mental health beyond individual risk factors by including the individual, leadership, institutional, and national context. By enabling analyses across hierarchical levels this dataset provides the necessary evidence to identify systemic drivers of mental (ill) health and inform the development of effective, system-wide strategies for meaningful change in academic work environments.


  • Open Access

    Advanced botanical authentication of honey: Using an ultrasensitive electrochemical genosensor and RT-qPCR for the detection of Castanea sativa

    by Stephanie Morais, Eduarda Pereira, Mariana Ferreira, Marlene Paulo Santos, Sónia Soares, Ana Luísa Teixeira, Valentina Fernandes Domingues, Cristina Delerue-Matos, Maria F. Barroso

    Food fraud is a reoccurring issue for the food industry, with significant public health and economic implications. Honey, a natural ingredient prized for its sweetness and inherent nutritional profile and health benefits, is one of the most frequently adulterated foods found in the international market. This fraudulent act not only damages the reputation of the honey industry but also presents a hazard to the consumers’ health. So, in this study, a disposable electrochemical genosensor was developed to detect Castanea sativa (chestnut tree) DNA in commercial honey samples. For this, a 103 bp C. sativa specific DNA-target oligonucleotide and its complementary probe were selected and designed. The genosensor methodology implied a sandwich hybridization format, for which the complementary sequence was cut into a 22 bp thiolated DNA-capture probe and an 81 bp fluorescein isothiocyanate-labelled DNA-signaling probe. Using chronoamperometric measurements, the enzymatic amplification of the electrochemical signal was obtained in a 0.03 to 1.00 nM concentration range, with a LOD and LOQ of 3.01 and 10.04 pM, respectively. The developed genosensor was able to detect the presence of the chestnut DNA in real chestnut plants and commercial honey samples. These results were then validated real-time quantitative PCR (RT-qPCR). In fact, conventional PCR coupled with gel electrophorese was not able to detect the presence of heather in honey. Therefore, electrochemical genosensors are a promising and cost-effective analytical tool to authenticate the botanical origin of honey, guaranteeing its safety, quality and authenticity.

  • Open Access

    Therapeutic drug monitoring education: The current state

    by Guenka Petrova, Stiliyana Blagova, Konstantin Tachkov, Marlene Santos, James Bluett, Merita Rumano, Elena Kkolou, Elena Drakalska, Marija Arev, Mehtap Cakmak Barsbay, et al.

    Aims: To evaluate available information on therapeutic drug monitoring (TDM) education programmes and their implementation across different countries. Methods: The study was performed in two phases. First, a scoping review of scientific literature on available education programmes was performed. Afterwards, a questionnaire was distributed among a worldwide network of professionals engaged in the practice of TDM. Results: Eight scientific articles discussing TDM educational programmes were found. They described in depth an educational programme on TDM, which was primarily offered as postgraduate education programme for hospital staff. We received a total 23 responses (30% response rate); of these, 68% were from academia. For 70% of respondents, TDM is part of the educational programme of healthcare professionals, and for 56% it is offered at both undergraduate and postgraduate level, aimed mainly at physicians (39%) and pharmacists (65%). TDM is mainly performed in infectious diseases (n = 15), neurology (n = 14) and psychiatry (n = 12), as well as for antibiotics (83%), monoclonal antibodies (53%), and oncology and psychotropics (48%). Funding for TDM is derived mostly from public health insurance (48%), hospital (44%), patients (39%). In some cases, patients might co‐pay to hospital or to health insurance fund. Conclusions: Education on TDM is scattered across different subjects, disciplines and degrees. It is oriented essentially towards physicians and pharmacists, and its funding is mainly public. General guidelines are lacking. In light of this, it is necessary to consider developing a comprehensive educational programme on TDM, oriented towards relevant drugs and diseases, and encompassing appropriate analytical and pharmacological methods.


  • Open Access

    Immunogenicity as a Predictor of Influenza Vaccine Efficacy: A Systematic Review

    by André Miguel Martins, Luis Félix Valero Juan, Marlene Santos, João P. Martins

    Background/Objectives: Influenza represents a significant burden on global public health, and vaccination is the most effective strategy to reduce it. The large investment in vaccination programs and the need for adjustments in vaccine serotypes are important reasons for evaluating the influenza vaccine’s efficacy every year. Establishing a relationship between immunogenicity data and efficacy is also crucial for predicting the efficacy of a vaccine during its development. Antibody response measurement is one of the most common methods for evaluating immunogenicity, particularly in vaccines and biologics. The aim of this systematic review was to define a model that relates the immunogenicity of a given vaccine to its efficacy, based on hemagglutination inhibition titer levels. Methods: To achieve this goal, information was gathered from articles linking immunogenicity with the efficacy of the influenza vaccine in the Medline and Scopus databases. Different mathematical models were developed and applied to assess the relationship between HAI titers and the effectiveness of the flu vaccine. This analysis was conducted for the various existing vaccines, for the different influenza virus strains, and for their efficacy in paediatric populations. Results: The r2 obtained ranged from 0.2579 to 0.966, which points to the importance of this immunological factor in the efficacy of the influenza vaccine. Conclusions: The efficacy values for titer level 40 confirm the validity of the data provided by Hobson.


  • Immunogenicity as a Predictor of Influenza Vaccine Efficacy

    by André Martins, Luis Félix Valero Juan, Marlene Santos, João Paulo Martins

    INPLASY202570064 Immunogenicity as a Predictor of Influenza Vaccine Efficacy Keywords: Influenza, Influenza vaccine, efficacy, immunogenicity. Read and download full-text here – PDF 202570064…

  • Open Access

    Vitamin K Epoxide Reductase Complex (VKORC1) Electrochemical Genosensors: Towards the Identification of 1639 G>A Genetic Polymorphism

    by Tiago Barbosa, Stephanie L. Morais, Renato Carvalho, Júlia M. C. S. Magalhães, Valentina F. Domingues, Cristina Delerue-Matos, Hygor Ferreira-Fernandes, Giovanny R. Pinto, Marlene Santos, Maria Fátima Barroso

    Anticoagulants, including warfarin, are often administered to patients who are exhibiting early symptoms of thromboembolic episodes or who have already experienced such episodes. However, warfarin has a limited therapeutic index and might cause bleeding and other clinical problems. Warfarin inhibits the vitamin K epoxide reductase complex subunit 1 (VKORC1), an enzyme essential for activating vitamin K, in the coagulation cascade. Genetic factors, such as polymorphisms, can change the natural function of VKORC1, causing variations in the medication reaction among individuals. Hence, before prescribing warfarin, the patient’s genetic profile should also be considered. In this study, an electrochemical genosensor capable of detecting the VKORC1 1639 G>A polymorphism was designed and optimized. This analytical approach detects the electric current obtained during the hybridization reaction between two 52 base pair complementary oligonucleotide sequences. Investigating public bioinformatic platforms, two DNA sequences with the A and G single-nucleotide variants were selected and designed. The experimental protocol of the genosensor implied the formation of a bilayer composed of a thiolate DNA and an alkanethiol immobilized onto gold electrodes, as well as the formation of a DNA duplex using a sandwich-format hybridization reaction through a fluorescein labelled DNA signalling probe and the enzymatic amplification of the electrochemical signal, detected by chronoamperometry. A detection limit of 20 pM and a linear range of 0.05–1.00 nM was obtained. A clear differentiation between A/A, G/A and G/G genotypes in biological samples was successfully identified by his novel device.


  • Open Access

    Data from the Researcher Mental Health Observatory STAIRCASE survey

    by Jana Lasser, Stefan Thomas Mol, Alja Čontala, Ana Slavec, Andreja Zulim de Swarte, Anna Khachatryan, Anna Maria Eleuteri, Anupoma Haque, Baiba Jansone, Blerina Vrenozi, et al.

    The data presented here derives from the STAIRCASE survey on researcher mental health. The survey reached 4,296 researchers predominantly from European countries who completed an online questionnaire about mental health outcomes such as depression, anxiety, stress, burnout, and well-being, as well as working conditions and leadership behaviour. Data and materials of the study are available at https://doi.org/10.21249/DZHW:remo:1.0.0 as a fully anonymised downloadable Campus Use File and a pseudonymised Scientific Use File, accessible in a secure remote analysis environment. Data can be reused for secondary analyses, educational purposes, or combined with similar data sets.

  • Open Access

    Warfarin Pharmacogenomics: Designing Electrochemical DNA-Based Sensors to Detect CYP2C9*2 Gene Variation

    by Tiago Barbosa, Stephanie L. Morais, Eduarda Pereira, Júlia M. C. S. Magalhães, Valentina F. Domingues, Hygor Ferreira-Fernandes, Giovanny Pinto, Marlene Santos, Maria Fátima Barroso

    Background/Objectives: The CYP2C9 enzyme is involved in the metabolism of warfarin. The CYP2C9 gene harbors several single-nucleotide polymorphisms (SNPs), including CYP2C9*2 (rs1799853), which is known to affect warfarin’s therapeutic response. So, it is important to develop analytical tools capable of genotyping these SNPs to adjust warfarin’s therapeutic outcomes. In this work, an electrochemical DNA-based sensor was constructed and optimized for the detection of the CYP2C9*2 polymorphism. Methods: Using bioinformatic database platforms, two 71 base pair DNA target probes with the polymorphic variants A and G were chosen and designed. A DNA-based sensor was composed by mercaptohexanol and the CYP2C9*2 DNA capture probe in a self-assembled monolayer connected to screen-printed gold electrodes. Two independent hybridization events of the CYP2C9*2 allele were designed using complementary fluorescein-labeled DNA signaling to improve selectivity and avoid secondary structures. Three human samples with the homozygous variant (G/G) and non-variant (A/A) and heterozygous (G/A) genotypes were amplified by PCR and then applied to the developed genosensor. Results: Chronoamperometry measurements were performed for both polymorphic probes. A calibration curve in the 0.25 to 2.50 nM (LOD of 13 pM) and another in the 0.15 to 5.00 nM range (LOD of 22.6 pM) were obtained for the homozygous non-variant and variant probes, respectively. This innovative tool was capable of identifying the hybridization reaction between two complementary strands of immobilized DNA, representing a genotyping alternative to the classical PCR methodology. Conclusions: The developed electrochemical DNA-based sensor was able to discriminate two synthetic SNP target sequences (Target-A and Target-G) and detect, with specificity, the three patients’ genotypes (G/G, G/A, and A/A). This tool is therefore a promising, sensitive, and cost-effective analytical way to determine and discriminate an individual’s genotype and predict the appropriate warfarin dose.


  • Open Access

    Exploring Alternative Potentialities of Portuguese and Spanish Craft Beers: Antioxidant and Photoprotective Activities

    by Maria João Pereira, Diana Santos, Agostinho Cruz, Ângelo Jesus, João P. Martins, Fernando Moreira, Marlene Santos, Cláudia Pinho, Ana Isabel Oliveira

    Craft beer has gained popularity due to its unique sensory characteristics and complex matrix with nutritional and potential health benefits. Studies linking beer consumption to skin conditions are limited, however, the high content of bioactive compounds is related to biological activities such as antibacterial, anti-inflammatory, anti-oxidative, and anti-carcinogenic. This study aims to evaluate the antioxidant, photoprotective and metabolic activity in human keratinocytes (HaCaT). Eighteen craft and four industrial beers were analyzed after dealcoholizing, degassing and freeze-drying. Total phenolic content (TPC) and antioxidant activity were determined. The most promising craft beer was studied for its photoprotective and metabolic activity. An India Pale Ale beer (ALM-IPA) presented the second best TPC (8.96 ± 0.64 mg of GAE/g) and promising antioxidant activity by ABTS (IC50 = 55.21 ± 4.68 µg/mL), H2O2 (IC50 = 23.54 ± 1.53 µg/mL) and FRAP (53.74 ± 1.27 µmol TE/g) assays. Regarding photoprotective activity, a solar photoprotection factor of 48.85 ± 0.39 was obtained. ALM-IPA showed no cytotoxicity up to a concentration of 250 µg/mL after 24 and 48 h of incubation. The potential benefits of beer extracts on skin can be seen, but further studies are essential to corroborate the findings and guarantee the safety of the extracts.